Could a single shot before surgery shield your heart?
NCT ID NCT06324461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single injection of a GLP-1 drug (dulaglutide), given 1 to 14 days before planned non-cardiac surgery, can reduce heart muscle injury in 372 adults at risk. Participants are randomly assigned to receive the drug or standard care. The goal is to see if this simple preventive step lowers heart damage and related complications after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duchess of Kent Children's Hospital at Sandy Bay
NOT_YET_RECRUITINGHong Kong, Hong Kong SAR, China
-
Queen Mary Hospital
RECRUITINGHong Kong, Hong Kong SAR, China
-
Tung Wah Hospital
RECRUITINGHong Kong, Hong Kong SAR, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new anesthetic shield elderly hearts during surgery?
- Heart attack aftermath: which treatment causes less internal bleeding?
- New heart scan and blood test could spot hidden damage after bypass
- Silent heart damage after leg artery treatment? new study investigates.
- Heart attack test gets a Tune-Up: new method aims to cut false positives
- Arm cuff therapy may shield heart and brain after stroke